Phaseline

Companies › Applied Pharmaceutical Science

Applied Pharmaceutical Science: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 1; Oncology.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
APS03118
RET inhibitor
RETPhase 1RET-altered Solid Tumors–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT05653869APS03118Phase 1RET-altered Solid TumorsOncologyOct 2026

Targets

RET (1)

Companies with the same targets

Roche Eli Lilly Beijing Scitech-Mq Pharmaceuticals Ellipses Pharma Taiho Pharmaceutical Jiangsu Hansoh Pharmaceutical Rigel Pharmaceuticals Chia Tai Tianqing Pharmaceutical Group Sichuan Kelun-Biotech Biopharmaceutical

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.